“Non-vitamin K antagonist oral anticoagulants (NOAC) in nonvalvular atrial fibrillation – in-group comparison”, Prospect. Pharm. Sci., vol. 20, no. 1, pp. 26–31, July 2022, doi: 10.56782/pps.36.